Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study

Shuichi Mizuta, Masashi Sawa, Hisashi Tsurumi, Kana Matsumoto, Kotaro Miyao, Takeshi Hara, Takeshi Takahashi, Reona Sakemura, Hiroshi Kojima, Akio Kohno, Mari S. Oba, Satoshi Morita, Junichi Sakamoto, Nobuhiko Emi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study'. Together they form a unique fingerprint.

Medicine & Life Sciences